In the United States, the POCT market is valued at USD 2.2 billion in 2025 and projected to reach USD 4.2 billion by 2035, ...
T-cell therapy has revolutionised the treatment of B-cell malignancies, offering durable responses for patients with relapsed or refractory disease. However, access globally remains limited due to ...
POLYVANTIS says its PLEXIGLAS and EUROPLEX films provide optical precision, chemical resistance, and biocompatibility for ...
In a boost to India’s fight against tuberculosis, apex health research body ICMR has validated new indigenously developed ...
The oncology-based molecular diagnostics market is being propelled by the increasing prevalence of cancer worldwide and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback